ChemoMetec A/S (0DZ0.L)
| Chiusura precedente | 778,50 |
| Aperto | 791,00 |
| Denaro | 0,00 x 0 |
| Lettera | 0,00 x 0 |
| Min-Max giorno | 791,00 - 810,50 |
| Intervallo di 52 settimane | 791,00 - 810,50 |
| Volume | |
| Media Volume | N/D |
| Capitalizzazione | 120,703M |
| Beta (5 anni mensile) | 1,54 |
| Rapporto PE (ttm) | 1,09 |
| EPS (ttm) | 7,55 |
| Prossima data utili | N/D |
| Rendimento e dividendo (forward) | N/D (N/D) |
| Data ex dividendo | N/D |
| Stima target 1A | N/D |
- GlobeNewswire
Management change
ANNOUNCEMENT NO. 233 14 December 2022 Management change Steen Søndergaard has announced that he wants to resign from his position as CEO of ChemoMetec A/S. It has been agreed that Steen Søndergaard remains in his position until a replacement has been found, however with resignation during the calendar year 2023 and possibly no later than 30 June 2023. The search for a new CEO has been initiated, and the Board of Directors expects to announce the name of the new CEO during the first quarter of 20
- GlobeNewswire
Q1 2022/23 - Good start to the fiscal year with 34% revenue growth
ANNOUNCEMENT NO. 232 Trading statement for Q1 2022/23 (1 July - 30 September 2022) Good start to the fiscal year with 34% revenue growth The financial year 2022/23 is off to a good start with revenue up 34% in the first quarter to DKK 113.8 million from DKK 85.0 million in the year-earlier period. While all product segments recorded growth, the North American market remains the main geographical growth driver. EBITDA amounted to DKK 65.2 million, a year-on-year increase of 50%, for an EBITDA mar
- GlobeNewswire
Annual Report 2021/22 - Strong growth despite challenging conditions
ANNOUNCEMENT NO. 229 15 September 2022 Annual Report 2021/22 (1 July 2021 - 30 June 2022) Strong growth despite challenging conditions ChemoMetec grew its revenue by 52% in 2021/22 from DKK 281.1 million to DKK 427.2 million despite the extraordinary market conditions caused by Covid-19 and the war in Ukraine, including supply chain shortages. As a result, EBITDA grew from DKK 135.6 million to DKK 222.9 million, a 64% increase. As in previous years, growth was primarily driven by increasing sale
